Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

MEREO BIOPHARMA GROUP PLC

(MREO)
  Report
Delayed Nasdaq  -  04:00 2022-12-09 pm EST
0.7798 USD   -1.92%
12/07Pharama Stocks Nudge European Equities Modestly Higher in Wednesday Trading
MT
12/05After Seesaw Opening, European Equities Little Changed in Monday Trading
MT
12/02European Equities Move Lower to End Strong Month, Week Lower
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Event chart MEREO BIOPHARMA GROUP PLC
Upcoming events on MEREO BIOPHARMA GROUP PLC
03/30/23 FY 2022 Earnings Release (Projected)
08/09/23 Interim 2023 Earnings Release (Projected)
03/28/24 FY 2023 Earnings Release (Projected)
Past events on MEREO BIOPHARMA GROUP PLC
11/18/22 | 09:00am Extraordinary Shareholders Meeting - Proxy Fight for Board Representation
11/15/22 | 07:55am Jefferies London Healthcare Conference - Fireside Chat
10/31/22 | 07:00am R&D Day
06/05/22 | 09:00am American Society of Clinical Oncology Meeting - Abstract No. 2651
05/09/22 | 10:30am ASTRAEUS Phase 2 Clinical Study Results Call
04/13/22 | 12:45pm Needham Virtual Healthcare Conference
03/31/22 | 04:01pm FY 2021 Earnings Release
03/14/22 | 09:00am R&D Day
02/17/22 | 08:00am SVB Leerink Global Healthcare Conference
11/30/21 | 08:30am Business Update Call
Past dividends on MEREO BIOPHARMA GROUP PLC

- No events available -

Annual results
Fiscal Period : December201720182019202020212022
Sales
M GBP
Released
Forecast
Spread


 


 


 


 
36,5
24,3
50%
 

 
Operating income
(EBITDA)
M GBP
Released
Forecast
Spread
-45,3
-51,7
12%
-35,2
-27,4
-28%


 
-36,0
-34,9
-3,1%


 
 

 
Operating profit
(EBIT)
M GBP
Released
Forecast
Spread
-45,3
-49,4
8,2%
-35,2
-30,2
-16%
-39,5
-38,3
-3,1%
-37,6
-35,3
-6,4%
-20,9
-36,6
43%
 
-43,3
 
Pre-Tax Profit
(EBT)
M GBP
Released
Forecast
Spread
-47,0
-50,2
6,5%
-37,3
-33,5
-11%
-41,1
-40,5
-1,4%
-166
-145
-15%
14,2
-8,10
276%
 
-40,2
 
Net income
M GBP
Released
Forecast
Spread
-38,8
-40,0
3,0%
-32,0
-26,3
-22%
-34,8
-39,2
11%
-164
-143
-14%
12,7
-9,31
237%
 
-9,99
 
EPS
GBP
Released
Forecast
Spread


 


 


 

-0,52
 
0,02
-0,02
253%
 
-0,03
 
Announcement Date03/23/201804/29/201906/15/202003/31/202103/31/2022-
Quarterly results
Fiscal Period : December2020 S22021 S12021 S22022 Q22022 S12022 Q1
Sales
M GBP
Released
Forecast
Spread


 
36,5

 


 


 


 
 

 
Operating profit
(EBIT)
M GBP
Released
Forecast
Spread
-20,9
-16,9
-24%
-0,20
-18,0
99%
-20,7
-19,0
-9,1%


 
-21,8
-18,8
-16%
 

 
Pre-Tax Profit
(EBT)
M GBP
Released
Forecast
Spread
-40,3
-16,9
-139%
10,9
-18,0
161%
3,34
-19,0
118%


 
-19,9
-19,0
-4,7%
 

 
Net income
Released
Forecast
Spread
-39,0
-16,9
-131%
12,1
-18,0
167%
0,64
-20,8
103%


 
-19,2
-19,0
-0,83%
 

 
EPS
Released
Forecast
Spread

-0,05
 
0,02
-0,03
174%
0,00
-0,05
101%


 
-0,03
-0,04
14%
 

 
Announcement Date03/31/202111/02/202103/31/202211/02/202211/02/202208/02/2022
Previous year Next Year
Upcoming sector events for MEREO BIOPHARMA GROUP PLC
More events
Past sector events for MEREO BIOPHARMA GROUP PLC
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise